WFH’s Global Summit on Women & Girls with Bleeding Disorders: July 8-10, 2021
The World Federation on Hemophilia will be hosting its Global Summit on Women & Girls with Bleeding Disorders from July 8-10, 2021. Additional details, including…
Read Our News
ISTH Webinar: COVID-19 Pandemic – A challenging era for hemostasis and thrombosis care
COVID-19 Pandemic – A challenging era for hemostasis and thrombosis care This virtual classroom will be hosted on June 1st, 2021, 09:30 - 10:30 ET (13:30 - 14:30…
FWGBD Welcomes New Board and MAC Members
The Foundation for Women & Girls with Blood Disorders is proud to announce the recent appointment of its newest board members, Sarah O’Brien, MD, MSc and…
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum
Clinical Guidance from the Anticoagulation Forum on Thromboembolism & Anticoagulant Therapy During COVID-19 Coronavirus disease 2019 (COVID-19) is a viral infection that can, in severe…
ISTH Provides New Guidance for Diagnosis, Treatment of VITT
The International Society on Thrombosis and Haemostasis (ISTH) has issued interim guidance for the diagnosis and treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT). This guidance,…
NHF’s April Webinar Series: Wednesdays from 2-3 pm ET
The National Hemophilia Foundation's Wednesday Webinars for April 2021 will feature an array of speakers and topics of interest to both healthcare providers and patients and…
Webinar: Call to Action: Structural Racism as a Fundamental Driver of Health Disparities, 3/18 at 1 pm EST
WEBINAR: Call to Action: Structural Racism as a Fundamental Driver of Health Disparities: A Presidential Advisory from the American Heart Association Time: Thursday | March…
MAC Member Dr. Jim Bussel Comments on Extremely Rare Cases of ITP in COVID-19 Vaccination Recipients
In a recent New York Times article, Dr. Jim Bussel, MD, Professor Emeritus at Weill Cornell Medicine and FWGBD Medical Advisory Committee Member, was asked…
Lisa Baumann Kreuziger, MD, MS, Praised by Dr. Fauci for COVID-19 Treatment Leadership
Dr. Lisa Baumann Kreuziger, MD, MS, Medical Director at the Versiti Blood Center of Wisconsin, recently received a personal letter of recognition from Dr. Anthony Fauci, White…
Webinar: Joint Guidelines on the Diagnosis and Management of von Willebrand Disease
The American Society of Hematology (ASH), International Society on Thrombosis and Hemostasis (ISTH), National Hemophilia Foundation (NHF), and World Federation of Hemophilia (WFH) came together to…
FWGBD Announces Additional Research Fellowship Award Opportunity
FWGBD Research Award: Promoting XXcellence in Women’s Health: Optimal Management of Women and Girls with Blood Disorders 1) FWGBD Special Research Grant Award 2020*Focus Area: Bleeding Disorders…
Updated Guidelines for Treatment of von Willebrand Disease
The American Society of Hematology (ASH) has developed clinical practice guidelines for the diagnosis and management of von Willebrand Disease (VWD) in partnership with the…
Register Now: Hemostatic Disorders in Women & Girls Colloquium, March 9, 2021
FWGBD is hosting its biennial colloquium on uterine hemostatic disorders on Tuesday, March 9, 2021, from 9:30 am - 12:30 pm ET, prior to HTRS/NASTH 2021. The colloquium will…
CDC Webinar on World Federation of Hemophilia Treatment Guidelines
The CDC is hosting a Public Health Webinar Series on Blood Disorders. This Webinar will discuss the World Federation of Hemophilia Treatment Guidelines and will…
Emerging Genetic Treatment Shows Promise for Severe Endometriosis
Researchers at Michigan State University have identified a potential genetic target for treating a severe, more painful form of endometriosis. The researchers have found a link…